Tags: Drug.

Fosamprenavir (marketed by ViiV Healthcare as fosamprenavir calcium) under the trade names Lexiva (U.S.) and Telzir (Europe) is a pro-drug of the protease inhibitor and antiretroviral drug amprenavir. The FDA approved it October 20 2003 while the EMEA approved it on July 12 2004. The human body metabolizes fosamprenavir in order to form amprenavir which is the active ingredient.

Fosamprenavir.svg
ATC prefix
J05
ATC suffix
AE07
CAS number
226700-81-8
DrugBank
DB01319
FDA UNII code
WOU1621EEG
IUPAC name
[(2R3S)-1-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-3-([(3S)-oxolan-3-yloxy]carbonylamino)-4-phenylbutan-2-yl]oxyphosphonic acid
PubChem
131536

Loading...

This page contains content from the copyrighted Wikipedia article "Fosamprenavir"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.